AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Loose Seton Prior to Surgery for Single-tract Cryptoglandular Fistula vs no Seton

RecruitingNAAges 18 Years - anyAllProctos Kliniek
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Cryptoglandular anal fistulas can cause pain, discharge, recurrent infection, and a prolonged treatment course. In current practice, patients with a single-tract mid-high or high cryptoglandular anal fistula often first undergo placement of a loose seton before definitive sphincter-preserving surgery. Although this staged approach is widely used, high-quality evidence showing that preoperative seton placement improves healing or other patient outcomes is limited. The SETON trial is a multicenter, randomized, controlled non-inferiority trial that compares two accepted treatment strategies: loose seton placement for approximately 8 weeks followed by definitive sphincter-preserving surgery versus direct sphincter-preserving surgery without prior seton placement. The study aims to determine whether omitting routine seton placement is not inferior in terms of fistula closure 26 weeks after t

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older * Single-tract non-purulent mid-high or high cryptoglandular anal fistula * Eligible for sphincter-preserving surgical treatment * Able to complete Dutch-language questionnaires sent by email * Written informed consent provided Exclusion Criteria: * Anorectal abscess * Multiple or complex anorectal fistulas * Inflammatory bowel disease or clinical suspicion requiring further investigation * History of anorectal malignancy * Use of immunosuppressive medication at the time of surgery * History of pelvic radiation * Pregnancy or lactation
๐Ÿ’Š

What it tests

  • No seton placement prior to surgery
๐Ÿ“

Where

2 sites
Ziekenhuis Amstelland
Amstelveen, Netherlands
Proctos Kliniek
Bilthoven, Netherlands
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy